ArticleThe Journal of infection2023

The effect of nirmatrelvir plus ritonavir on the long-term risk of epilepsy and seizure following COVID-19: A retrospective cohort study including 91,528 patients.

Ting-Hui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.